SU508186A3 - Способ получени -замещенных лактамов - Google Patents

Способ получени -замещенных лактамов

Info

Publication number
SU508186A3
SU508186A3 SU1893858A SU1893858A SU508186A3 SU 508186 A3 SU508186 A3 SU 508186A3 SU 1893858 A SU1893858 A SU 1893858A SU 1893858 A SU1893858 A SU 1893858A SU 508186 A3 SU508186 A3 SU 508186A3
Authority
SU
USSR - Soviet Union
Prior art keywords
hydrogen
acid
formula
carbon atoms
kip
Prior art date
Application number
SU1893858A
Other languages
English (en)
Russian (ru)
Inventor
Оноре Люсьен Мишель Струббе Жозеф
Арман Ленц Раймон
Original Assignee
Юньон Шимик-Шемиш Бедрижвен (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юньон Шимик-Шемиш Бедрижвен (Фирма) filed Critical Юньон Шимик-Шемиш Бедрижвен (Фирма)
Application granted granted Critical
Publication of SU508186A3 publication Critical patent/SU508186A3/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2632-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/272-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SU1893858A 1970-02-13 1971-02-12 Способ получени -замещенных лактамов SU508186A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB697870A GB1309692A (en) 1970-02-13 1970-02-13 N-substituted lactams

Publications (1)

Publication Number Publication Date
SU508186A3 true SU508186A3 (ru) 1976-03-25

Family

ID=9824325

Family Applications (2)

Application Number Title Priority Date Filing Date
SU1893858A SU508186A3 (ru) 1970-02-13 1971-02-12 Способ получени -замещенных лактамов
SU1621307A SU508185A3 (ru) 1970-02-13 1971-02-12 Способ получени -замещенных лактамов

Family Applications After (1)

Application Number Title Priority Date Filing Date
SU1621307A SU508185A3 (ru) 1970-02-13 1971-02-12 Способ получени -замещенных лактамов

Country Status (15)

Country Link
JP (2) JPS535301B1 (cg-RX-API-DMAC7.html)
BE (1) BE762728R (cg-RX-API-DMAC7.html)
CH (1) CH530395A (cg-RX-API-DMAC7.html)
CS (2) CS167911B2 (cg-RX-API-DMAC7.html)
DE (1) DE2106418C2 (cg-RX-API-DMAC7.html)
DK (1) DK137451B (cg-RX-API-DMAC7.html)
ES (1) ES388135A2 (cg-RX-API-DMAC7.html)
FI (1) FI54916C (cg-RX-API-DMAC7.html)
FR (1) FR2081508B2 (cg-RX-API-DMAC7.html)
GB (1) GB1309692A (cg-RX-API-DMAC7.html)
MY (1) MY7400072A (cg-RX-API-DMAC7.html)
NL (1) NL168830C (cg-RX-API-DMAC7.html)
SU (2) SU508186A3 (cg-RX-API-DMAC7.html)
YU (2) YU34876B (cg-RX-API-DMAC7.html)
ZA (1) ZA71877B (cg-RX-API-DMAC7.html)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1045043B (it) * 1975-08-13 1980-04-21 Isf Spa Derivati pirrolidinici
GB1583871A (en) * 1976-10-19 1981-02-04 Ucb Sa Anti-aggregants
BE864269A (fr) * 1977-03-03 1978-06-16 Parke Davis & Co Nouveaux n-(aminoalkyl substitue)-2-oxo-1-pyrrolidine-acetamides et procedes pour les produire
ATE27T1 (de) * 1978-05-08 1981-04-15 Ucb Sa Lactam-n-essigsaeuren und ihre amide, verfahren zu ihrer herstellung und heilmittel, die sie enthalten
IT1141287B (it) * 1979-06-13 1986-10-01 Nattermann A & Cie Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono
FR2515179A1 (fr) * 1981-07-24 1983-04-29 Hoffmann La Roche Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique
EP0089900B1 (en) * 1982-03-24 1985-12-27 Prodes S.A. New n-((2-oxo-1-pyrrolidinyl)acetyl)piperazines, the methods of producing such new compounds and their salts as well as pharmaceutical preparations for therapeutic use containing these compounds or salts
GB8412357D0 (en) * 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
GB8412358D0 (en) * 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel
US4804400A (en) * 1986-09-12 1989-02-14 Ciba-Geigy Corporation N-phenyl-maleimides and herbicidal and plant growth regulating methods of use thereof
GB8827389D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of(s)alpha-ethyl-2-oxo-1-pyrrolidineacetamide
TW544311B (en) * 1998-08-06 2003-08-01 Daiichi Seiyaku Co Therapeutic or preventive agent for intractable epilepsies
GB0004297D0 (en) * 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
US6686477B2 (en) 2000-09-29 2004-02-03 Eastman Chemical Company Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same
EP1395560A1 (en) 2001-05-23 2004-03-10 Ucb, S.A. 2-oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivativ es for the treatment of epilepsy and other neurological disorders
ATE410412T1 (de) * 2001-08-10 2008-10-15 Ucb Pharma Sa Oxopyrrolidin verbindungen, verfahren zur herstellung dieser verbindungen und deren verwendung zur herstellung von levetiracetam und analogen
AU2002340971B2 (en) * 2001-10-08 2007-04-26 Ucb Use of 2-oxo-1-pyrrolidine derivatives for the treatment of dyskinesia and movement disorders
CN1802352A (zh) 2003-02-03 2006-07-12 特瓦制药工业有限公司 制备左乙拉西坦的方法
ES2214147B1 (es) 2003-02-28 2005-10-01 Farma-Lepori S.A. Procedimiento de obtencion de un agente antiepileptico.
CA2497062A1 (en) 2004-02-18 2005-08-18 Dr. Reddy's Laboratories Limited Preparation of amino acid amides
CA2488325C (en) 2004-11-22 2010-08-24 Apotex Pharmachem Inc. Improved process for the preparation of (s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide and (r)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
WO2006095362A1 (en) * 2005-03-10 2006-09-14 Rubamin Limited Process for preparing levetiracetam
AU2006254336B9 (en) 2005-06-01 2013-02-28 Ucb Pharma, S.A. 2 -oxo-I -pyrrolidine derivatives/ processes for preparing them and their therapeutic use on the central nervous system
EP2147911A1 (en) 2008-07-24 2010-01-27 ZaCh System S.p.A. Process for the preparation of levetiracetam
EA033130B1 (ru) 2008-10-16 2019-08-30 Дзе Джонс Хопкинс Юниверсити Способы и композиции для улучшения когнитивной функции
US8785661B2 (en) 2009-05-13 2014-07-22 Nektar Therapeutics Oligome-containing pyrrolidine compounds
US7939676B2 (en) 2009-09-17 2011-05-10 Zach System S.P.A. Process for the preparation of levetiracetam
EA037187B1 (ru) 2010-02-09 2021-02-17 Дзе Джонс Хопкинс Юниверсити Способ и композиция для лечения когнитивного расстройства
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
AU2014228512A1 (en) 2013-03-15 2015-10-01 Agenebio, Inc. Methods and compositions for improving cognitive function
US10806717B2 (en) 2013-03-15 2020-10-20 The Johns Hopkins University Methods and compositions for improving cognitive function
CN109999033B (zh) 2014-01-21 2022-12-23 詹森药业有限公司 包括代谢型谷氨酸能受体亚型2的正别构调节物或正位激动剂的组合及其用途
HRP20191646T1 (hr) 2014-01-21 2019-12-13 Janssen Pharmaceutica Nv Kombinacije koje sadržavaju pozitivne alosteričke modulatore ili ortosteričke agoniste metabotropnog glutamatergičnog receptora podtip 2 i njihova uporaba
CN104059010A (zh) * 2014-06-12 2014-09-24 浙江华海药业股份有限公司 一种制备2-(2-氧代吡咯烷-1-基)-丁酸酯的方法
CN106591179B (zh) * 2016-12-05 2018-07-03 长兴制药股份有限公司 甲基包囊菌及其在选择性拆分制备(S)-α-乙基-2-氧-1-吡咯烷乙酸盐上的应用
RU2663899C1 (ru) * 2017-07-19 2018-08-13 Федеральное государственное унитарное предприятие "Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" Способ получения 1-карбамоилметил-4-фенил-2-пирролидона
US11384050B1 (en) 2021-02-03 2022-07-12 Vitaworks Ip, Llc Method for preparing levetiracetam and intermediates thereof
CN113979911A (zh) * 2021-11-12 2022-01-28 汤斌 一种从大鲵肽中提取乙拉西坦的方法
AU2023324882A1 (en) 2022-08-19 2025-03-20 Agenebio, Inc. Benzazepine derivatives, compositions, and methods for treating cognitive impairment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams

Also Published As

Publication number Publication date
CH530395A (fr) 1972-11-15
DK137451B (da) 1978-03-06
FI54916C (fi) 1979-04-10
DK137451C (cg-RX-API-DMAC7.html) 1978-07-24
CS167912B2 (cg-RX-API-DMAC7.html) 1976-05-28
ZA71877B (en) 1971-10-27
JPS53130656A (en) 1978-11-14
YU34876B (en) 1980-04-30
DE2106418C2 (de) 1983-12-22
YU30671A (en) 1979-10-31
FR2081508A2 (cg-RX-API-DMAC7.html) 1971-12-03
DE2106418A1 (de) 1971-08-19
ES388135A2 (es) 1973-05-01
JPS535301B1 (cg-RX-API-DMAC7.html) 1978-02-25
GB1309692A (en) 1973-03-14
NL168830C (nl) 1982-05-17
BE762728R (fr) 1971-08-10
CS167911B2 (cg-RX-API-DMAC7.html) 1976-05-28
NL7101697A (cg-RX-API-DMAC7.html) 1971-08-17
NL168830B (nl) 1981-12-16
SU508185A3 (ru) 1976-03-25
JPS5420491B2 (cg-RX-API-DMAC7.html) 1979-07-23
MY7400072A (en) 1974-12-31
FR2081508B2 (cg-RX-API-DMAC7.html) 1975-06-06
YU144578A (en) 1982-10-31
FI54916B (fi) 1978-12-29

Similar Documents

Publication Publication Date Title
SU508186A3 (ru) Способ получени -замещенных лактамов
SU507234A3 (ru) Способ получени 1,4-дигидропиридинов или их солей
US2654738A (en) Organic derivatives of phosphonic acids and method of preparing the same
SU555846A3 (ru) Способ получени амидов 5-ацетамидо-2,4,6-трийодизофталевой кислоты
NO761050L (cg-RX-API-DMAC7.html)
MX2023006323A (es) Surfactantes de n-acil aminoacido y derivados de estos.
RU2710939C1 (ru) Способ получения регулятора роста растений N-(изопропоксикарбонил)этаноламина
CZ288652B6 (cs) Způsob přípravy derivátů kyseliny gama-merkaptokarboxylové
US4537714A (en) Process for the preparation of lower alkyl esters of N-L-α-aspartyl-L-phenylalanine and of new intermediates for their preparation
US2467895A (en) Piperazine derivatives and method of preparing the same
US2496163A (en) Synthesis of a 2-substituted-5-oxopyrrolidine
US3153077A (en) Process for preparing organic bis-thiosulfates
SU1292666A3 (ru) Способ получени гидрохлорида или кислого фумарата 1,1-ди(н-пропил)-н-бутиламина
US2169971A (en) Sulphonic acid amide compounds
GB823001A (en) Acaricidal compositions
Moersch et al. Chloromycetin. 1 Related Compounds. The β-p-Nitrophenylserines
US2090595A (en) Process of preparing amido derivatives
SU464116A3 (ru) Способ получени замещенных аминоалкильных эфиров тиолкарбаминовой кислоты
SU558639A3 (ru) Способ получени производных аминооксигидроксамовой кислоты или их солей
SU491635A1 (ru) Способ получени производных 2этинилпиперазина
SU523082A1 (ru) Способ получени оксиалкиламидов -ацилглицина
SU477159A1 (ru) Способ получени амидофосфорилоксиэтиламидов карбоновых кислот
NO135092B (cg-RX-API-DMAC7.html)
JP7465584B2 (ja) 結晶性エリブリン塩
US2856421A (en) Crystalline salts of pantothenic acid